Cxbladder Is a Suite of Tests Designed To Rule Out Urothelial Bladder Cancer
Cxbladder is a suite of non-invasive genomic urine tests optimised for haematuria evaluation and the surveillance of non-muscle invasive bladder cancer.
Cxbladder is a suite of non-invasive genomic urine tests optimized for the rule out of urothelial bladder cancer, the most common form of the disease. The test combines clinical risk factors with gene expression markers to quickly and accurately rule out cancer, reducing the need for further invasive procedures when you're at low risk of disease.
You should consider a Cxbladder test when you’ve seen blood in your urine, when tests reveal you have blood in your urine, or when you’ve had non-muscle invasive bladder cancer and are being monitored for recurrence. A Cxbladder test can provide peace of mind, helping to resolving diagnostic ambiguity while reducing the need for invasive cystoscopies which can be uncomfortable and inconvenient. As a non-invasive monitoring alternative, the test can reduce the frequency of surveillance cystoscopy required in many patients.
With performance validated in over 20 peer-reviewed studies, Cxbladder’s proven accuracy makes it a reliable choice.
Take control of your care. Cxbladder provides meaningful results that will help you and your doctor make informed diagnosis and management decisions.
Learn more about Cxbladder Contact us for more information
Bladder Cancer Detection
Globally, bladder cancer is the sixth most common cancer in men, and the 10th most common overall. The most common sign of bladder cancer is blood in urine (or hematuria), however patients may experience a range of other symptoms such as urinary irritation and/ or changes in the frequency, urgency, or ease of urination.
Several tests and procedures are available to determine whether an individual has bladder cancer or to establish an alternative diagnosis. Some of these clarify the presence of symptoms (such as hematuria) and others identify alternative causes of these symptoms (such as an infection). Importantly, these tests and procedures are used in combination to determine an overall diagnosis.
Learn more about bladder cancer symptoms Browse our overview of bladder cancer detection
Tests and procedures used in detection, rule-out, and diagnosis include:
Urine-based Tests
Non-invasive urine-based tests can be used to determine if blood or other substances are present in a sample, whether an infection may be the root cause of symptoms, and if microscopic cancer or pre-cancer cells are visible. Genomic tests like Cxbladder analyse biomarker genes to help rule out cancer, reducing the need for further invasive procedures.
Learn more about urine test detection Learn more about Cxbladder
Imaging
Imaging techniques like an ultrasound, which use high frequency waves to produce images of internal organs and tissue, and CT scans, which use x-rays to obtain cross-sectional images of the body, are often used to determine if abnormalities are present, particularly in the upper urinary tract and kidneys.
Learn more about imaging techniques
Last Updated: 25 Jun 2021 11:29 am
-
Comprehensive solution for your clinical needs
Cxbladder gives you actionable results that can make a meaningful difference in your patient’s diagnosis and treatment.
Learn more about Cxbladder’s clinical applications -
Cxbladder sampling process
Cxbladder is a suite of non-invasive tests that is easy and straightforward to use.
Watch the instructional video here -
Talk to a Rep
Contact us by phone or email, or fill out an online form and a Cxbladder representative will get back to you.
Complete an information request form today